These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12533270)

  • 21. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.
    Rugo HS; Ahles T
    Semin Oncol; 2003 Dec; 30(6):749-62. PubMed ID: 14663776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive deficits are usually mild in patients with breast cancer after chemotherapy.
    Barton MK
    CA Cancer J Clin; 2013 Jan; 63(1):3-4. PubMed ID: 23169539
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.
    Schagen SB; Hamburger HL; Muller MJ; Boogerd W; van Dam FS
    J Neurooncol; 2001 Jan; 51(2):159-65. PubMed ID: 11386413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.
    Cheung YT; Chui WK; Chan A
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):99-111. PubMed ID: 22015329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB; van Dam FS
    J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract]   [Full Text] [Related]  

  • 26. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.
    Maruff P; Falleti MG; Collie A
    Cancer; 2004 Nov; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092
    [No Abstract]   [Full Text] [Related]  

  • 27. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Schagen SB
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):87-101. PubMed ID: 23768778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulating evidence for the effect of chemotherapy on cognition.
    Rodin G; Ahles TA
    J Clin Oncol; 2012 Oct; 30(29):3568-9. PubMed ID: 22927529
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of the effect of chemotherapy on ovarian function in women with breast cancer.
    Anderson RA; Cameron DA
    J Clin Oncol; 2007 Apr; 25(12):1630-1; author reply 1632. PubMed ID: 17443008
    [No Abstract]   [Full Text] [Related]  

  • 30. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
    J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment.
    Natori A; Ogata T; Sumitani M; Kogure T; Yamauchi T; Yamauchi H
    Clin Cancer Res; 2015 Mar; 21(6):1348-52. PubMed ID: 25589615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
    Dutta V
    J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy-related cognitive dysfunction in breast cancer.
    O'Shaughnessy J
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):17-24. PubMed ID: 14702917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
    Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
    Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
    J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.
    Hermelink K
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):67-9. PubMed ID: 26063891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.